Featured Cancer Clinical Trials

Head and Neck Cancer
CASE 6316
A Phase II Study of the Addition of Pembrolizumab to Postoperative Radiotherapy in Resected High Risk Cutaneous Squamous Cell Cancer of the Head and Neck.
View full trial information.

Leukemia, Acute Myeloid (AML)
PFIZ 2918
A Randomized (1:1), Double-Blind, Multi-Center, Placebo Controlled Study Evaluating Intensive Chemotherapy With Or Without Glasdegib (PF-04449913) Or Azacitidine (Aza) With Or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia.
View full trial information.

Multiple Myeloma
ROCH 1A18
A Phase Ib study of the safety and pharmacokinetics of atezolizumab (anti-pd-l1 antibody) alone or in combination with an immunomodulatory drug and/or daratumumab in patients with multiple myeloma (relapsed/refractory and post-autologous stem cell transplantation).
View full trial information.

Brain, Glioblastoma
CASE 3313
A prospective phase II trial of NovoTTF-100A with Bevacizumab (Avastin) in Patients with Recurrent Glioblastoma.
View full trial information.

Bladder Cancer, Breast Cancer, Colorectal Cancer, Melanoma, NSCLC (Non-small cell lung cancer), Prostate Cancer, Renal Cancer
CPI 1Y16
A Phase 1/1b, Open-Label, Multicenter, Repeat-Dose, Dose-Selection Study of CPI-444 as Single Agent and in Combination with Atezolizumab in Patients with Selected Incurable Cancers.
View full trial information.

All Cancer Types, Lymphoma
EAY 131
Molecular Analysis for Therapy Choice (MATCH).
View full trial information.

Search our Cancer Clinical Trials Database for a full listing of all open and accruing studies.